U.S. and international wheat breeders said Friday publication of the gene map of wheat could eventually help in developing beneficial new varieties, but cautioned that cracking wheat’s complicated genetic code is far from completed.
Read MoreMonsanto Co has acquired a 19.9 percent minority interest in InterGrain Pty Ltd, an Australian cereal breeder, in its effort to bring biotech wheat to world markets, the company said on Thursday. The stake is part of a collaboration agreement that includes the exchange of wheat germplasm for breeding aimed at developing wheat varieties with improved yield performance, enhanced disease resistance and drought tolerance, as well as improved end use qualities, the companies said.
Read MoreProponents of tighter U.S. oversight of biotech crops said on Monday a court-ordered ban on genetically-modified sugar beets is a key ruling that should lead to more thorough regulatory review of such crops. And they threatened further court action against the U.S. Department of Agriculture if the agency does not start examining the environmental and economic harm potentially associated with such crops.
Read MoreA grass-roots group of U.S. farmers and ranchers on Tuesday called for tighter government oversight of beef and poultry companies, charging that corporate monopolies are unfairly squeezing independent producers. The outcry is aimed at rallying support for the Agriculture Department’s Grain Inspection, Packers and Stockyards Administration (GIPSA), which is completing a new rule aimed at promoting fairness in the marketing of livestock and poultry. GIPSA published the rule in June and a comment period expires Nov 22.
Read MoreMonsanto Co said on Thursday it will maintain the export approval status for Roundup Ready soybeans through 2021, seven years after the company’s patent expires on the popular seed product. However, farm industry players called for further action to ensure continued availability of the biotech seed.
Read MoreMonsanto Co has agreed to pay a $2.5 million fine for misbranding biotech cotton seeds in what regulators called the largest settlement of its kind for violating U.S. insecticide law. Monsanto, the world’s largest seed company, violated the Federal Insecticide, Fungicide and Rodenticide Act when it sold and distributed some cotton seed products in a way that violated restrictions Monsanto had told the U.S. Environmental Protection Agency it would adhere to, the EPA said.
Read MoreMonsanto Co and BASF said Wednesday they will nearly double their investments into an already established joint venture to develop biotech crops, expanding their efforts to include a focus on wheat, a key food crop that as yet has no commercialized biotech variety. The companies said they were adding potentially more than $1 billion to the collaboration they formed in 2007, which already had a budget of about $1.5 billion and has been focused on developing higher-yielding and stress-tolerant versions of corn, soy, cotton and canola.
Read MoreMonsanto Co reported a 45 percent drop in quarterly net income on Wednesday as the global seed leader’s Roundup herbicide business continued to struggle, sending its shares down as much as 4.3 percent. Company officials, who called 2010 a “challenging year,” said while they saw a 5 percent jump in net sales of seeds and genomics, net sales of Roundup and other glyphosate-based herbicides fell 56 percent.
Read MoreWest Virginia officials have notified global seed giant Monsanto Co that they are probing whether or not the company engaged in unfair or deceptive practices in marketing its new genetically altered soybean seeds. The West Virginia Office of the Attorney General said in a letter to Monsanto dated June 24 that it wants to meet with officials from the St. Louis-based company to discuss investigators’ concerns that Monsanto has violated consumer protection laws.
Read MoreA U.S. Supreme Court ruling in a case pitting environmentalists against biotech seed giant Monsanto Co could speed up a resumption of sales of genetically altered alfalfa, though any commercialization still depends on action by U.S. regulators.
Read More